Tower Research Capital LLC (Trc) Alpha Tau Medical Ltd. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$0.65 - $11.0 $4,074 - $68,959
6,269 New
6,269 $37,000
Q2 2022

Aug 15, 2022
SELL
$5.19 - $12.67 $15,673 - $38,263
-3,020 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$8.92 - $15.3 $26,938 - $46,206
3,020 New
3,020 $36,000

Others Institutions Holding DRTS

# of Institutions
29
Shares Held
1.36M
Call Options Held
0
Put Options Held
0
View Full List

About Alpha Tau Medical Ltd.

DRTS Quotes by TradingView
  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $213M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email